BIOMOLECULAR_COMP

Biomolecular computers

 Coordinatore WEIZMANN INSTITUTE OF SCIENCE 

Spiacenti, non ci sono informazioni su questo coordinatore. Contattare Fabio per maggiori infomrazioni, grazie.

 Nazionalità Coordinatore Israel [IL]
 Totale costo 2˙125˙980 €
 EC contributo 2˙125˙980 €
 Programma FP7-IDEAS-ERC
Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call ERC-2008-AdG
 Funding Scheme ERC-AG
 Anno di inizio 2009
 Periodo (anno-mese-giorno) 2009-01-01   -   2013-10-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    WEIZMANN INSTITUTE OF SCIENCE

 Organization address address: HERZL STREET 234
city: REHOVOT
postcode: 7610001

contact info
Titolo: Ms.
Nome: Talia
Cognome: Tzahor
Email: send email
Telefono: +972 8 934 4026
Fax: +972 8 934 4165

IL (REHOVOT) hostInstitution 2˙125˙980.00
2    WEIZMANN INSTITUTE OF SCIENCE

 Organization address address: HERZL STREET 234
city: REHOVOT
postcode: 7610001

contact info
Titolo: Prof.
Nome: Ehud
Cognome: Shapiro
Email: send email
Telefono: +972 8 934 4506
Fax: +972 8 934 4118

IL (REHOVOT) hostInstitution 2˙125˙980.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

laboratory    medical    delivered    doctor    environment    computing    disease    biological    autonomous    cell    cells    device    molecular   

 Obiettivo del progetto (Objective)

'Autonomous programmable computing devices made of biological molecules hold the promise of interacting with the biological environment in future biological and medical applications. Our laboratory's long-term objective is to develop a 'Doctor in a cell': molecular-sized device that can roam the body, equipped with medical knowledge. It would diagnose a disease by analyzing the data available in its biochemical environment based on the encoded medical knowledge and treat it by releasing the appropriate drug molecule in situ. This kind of device might, in the future, be delivered to all cells in a specific tissue, organ or the whole organism, and cure or kill only those cells diagnosed with a disease. Our laboratory embarked on the attempt to design and build these molecular computing devices and lay the foundation for their future biomedical applications. Several important milestones have already been accomplished towards the realization of the Doctor in a cell vision. The subject of this proposal is a construction of autonomous biomolecular computers that could be delivered into a living cell, interact with endogenous biomolecules that are known to indicate diseases, logically analyze them, make a diagnostic decision and couple it to the production of an active biomolecule capable of influencing cell fate.'

Altri progetti dello stesso programma (FP7-IDEAS-ERC)

SPEAR (2014)

Series-Parallel Elastic Actuators for Robotics

Read More  

TRIPLE-BC (2013)

Identification and functional validation of drugable targets/pathways for triple negative breast cancer

Read More  

GUTDROSO (2009)

Gut immunity and homeostasis in Drosophila

Read More